Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2025

Complete Recovery From Tachycardiomyopathy and Atrial Fibrillation Through Targeted Mitochondrial Support: A Case Report

View Full Paper
Ask AI
Bookmark
Share

Authors

ESElmar Schwarz

Discussion

Loading...

Member takes

Overview

Case report shows complete recovery in a patient with tachycardiomyopathy and atrial fibrillation, highlighting mitochondrial dysfunction's role in heart failure.

Key Points

  • A 52-year-old male with tachycardiomyopathy saw LVEF improve from 20-25% to 60% through mitochondrial support.
  • Initial tests indicated severe heart failure and electrolyte imbalances before diuretic treatment normalized levels.
  • Conventional therapies failed, prompting the use of mitochondrial-targeted therapies like ubiquinone and NAC.
  • This case indicates potential for mitochondrial interventions in managing refractory heart failure related to tachycardiomyopathy.

Cite This Study

Elmar Schwarz (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d14a2https://doi.org/10.21203/rs.3.rs-7022774/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Case of Success: Guidelines-Based Treatment to Control Atrial Fibrillation-Induced Cardiomyopathy—Atrioventricular Node Ablation and Cardiac Resynchronization Therapy to the Rescue2025
  2. 2Reviving the Mitochondria: A Hopeful Horizon in Refractory Heart Failure2025
  3. 3Mitochondrial Dysfunction in Diabetic Cardiomyopathy: New Therapeutic Targets2025
  4. 4Catheter ablation combined with left bundle optimized cardiac resynchronization therapy for persistent atrial fibrillation complicated with malignant arrhythmia: A case report2025
  5. 5Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case report2025